AMGN vs WST
By Alex · Tickerpine
Amgen Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | WST |
|---|---|---|
| Price | $358.33 | $350.85 |
| Market cap | $193.39B | $24.79B |
| P/E ratio | 24.9 | 47.0 |
| ROE | 101.32% | 19.13% |
| Profit margin | 20.96% | 16.85% |
| Revenue growth | 5.80% | 21.00% |
| Dividend yield | 2.81% | 0.25% |
| Beta | 0.42 | 1.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs WST in plain English
- AMGN is the bigger company — about 7.8× the market cap of WST.
- AMGN is cheaper on earnings (P/E 24.9 vs 47.0).
- AMGN earns a higher return on equity (101% vs 19%).
- WST is growing revenue faster (21% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 0.25%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.